stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Neurocrine Biosciences IncNBIX
$162.861.84%-3.06
Pre-market: 163.50+0.64 +0.39%

Neurocrine Biosciences Inc (NBIX)

Neurocrine Biosciences Inc Stock (NBIX) Forecast

The Neurocrine Biosciences Inc (NBIX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $159.86, representing a -1.84% decrease from the current price of $162.86. The highest analyst price target is $164.86, and the lowest is $154.86.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month NBIX Price Target
Average 175.37 (+7.68% Downside)

Is Neurocrine Biosciences Inc (NBIX) A Buy Now?

Oscillators
NameValueAction
RSI(14)57.31Neutral
STOCH(9,6)58.87Neutral
STOCHRSI(14)15.96Buy
MACD(12,26)5.88Buy
ADX(14)32.87Buy
William %R-38.03Neutral
CCI(14)1.66Neutral
Buy: 3 · Sell: 0 · Neutral: 4Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
166.77
Sell
164.40
Sell
MA20
157.99
Buy
159.64
Buy
MA50
149.14
Buy
154.31
Buy
MA100
157.22
Buy
153.36
Buy
MA200
149.28
Buy
151.15
Buy
Buy: 8 · Sell: 2 · Neutral: 0Summary: Buy

According to our latest analysis, NBIX could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on NBIX, as trading bullish markets is always a lot easier

  1. RSI (Relative Strength Index): The RSI(14) value of 57.31 indicates that NBIX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 58.87 indicates that NBIX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.96 indicates that NBIX is oversold. This suggests that NBIX price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 32.87 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of 1.66 indicates that NBIX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term NBIX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Neurocrine Biosciences Inc financial reports and earnings history, Neurocrine Biosciences Inc (NBIX) stock could reach $272.90 by 2030, $471.15 by 2040 and $579.59 by 2050. See the projected annual prices until 2050 of the Neurocrine Biosciences Inc stock below:

  • Neurocrine Biosciences Inc (NBIX) is expected to reach an average price of $360.68 in 2035, with a high prediction of $381.55 and a low estimate of $339.00. This indicates an +121.47% change from the last recorded price of $162.86.
  • Neurocrine Biosciences Inc (NBIX) stock is projected to chart a bullish course in 2040, with an average price target of $466.64, representing an +186.53% change from its current level. The forecast ranges from a conservative $384.61 to a sky-high $471.15.
  • Our analysts predict Neurocrine Biosciences Inc (NBIX) to change +217.50% by 2045, soaring from $467.32 to an average price of $517.08, potentially reaching $519.75. While $467.32 is the low estimate, the potential upside is significant.
  • Neurocrine Biosciences Inc (NBIX) stock is expected to climb by 2050, reaching an average of $566.97, a +248.13% change from its current level. However, a wide range of estimates exists, with high and low targets of $579.59 and $486.07, respectively, highlighting the market's uncertainty.

Neurocrine Biosciences Inc Stock (NBIX) Year by Year Forecast

Neurocrine Biosciences Inc Stock (NBIX) Price Forecast for 2026

The predicted value for Neurocrine Biosciences Inc (NBIX) in 2026 is set at an average of $149.06. Estimates vary from a peak of $186.12 to a trough of $122.14, indicating an -8.47% surge from the present price of $162.86.

MonthAverageLowHighChange from today's price
December, 2026$162.09$154.86$164.86-0.47%

Neurocrine Biosciences Inc Stock (NBIX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Neurocrine Biosciences Inc (NBIX) is $179.61, with a high forecast of $213.92 and a low forecast of $149.55. This indicates an +10.28% increase from the last price of $162.86.

MonthAverageLowHighChange from today's price
January, 2027$153.00$149.55$166.61-6.05%
February, 2027$164.33$150.40$165.29+0.90%
March, 2027$169.21$162.30$172.53+3.90%
April, 2027$176.39$168.34$176.58+8.31%
May, 2027$161.49$160.99$181.77-0.84%
June, 2027$176.33$157.41$176.94+8.27%
July, 2027$181.97$171.89$182.78+11.74%
August, 2027$180.15$176.75$184.27+10.61%
September, 2027$192.75$176.61$194.79+18.36%
October, 2027$193.16$188.35$195.14+18.61%
November, 2027$196.00$187.33$201.18+20.35%
December, 2027$210.49$195.29$213.92+29.25%

Neurocrine Biosciences Inc Stock (NBIX) Price Forecast for 2028

In 2028, Neurocrine Biosciences Inc (NBIX) is projected to reach an average price of $200.12, with a high projection of $219.40 and a low estimate of $185.12. This indicates an +22.88% rise from the last price of $162.86.

MonthAverageLowHighChange from today's price
January, 2028$216.60$200.37$219.08+33.00%
February, 2028$210.13$205.75$216.31+29.02%
March, 2028$199.84$197.36$215.93+22.71%
April, 2028$196.03$192.03$203.16+20.36%
May, 2028$187.86$186.50$196.30+15.35%
June, 2028$197.28$187.38$199.43+21.14%
July, 2028$189.69$188.74$203.16+16.47%
August, 2028$189.95$185.12$192.27+16.63%
September, 2028$191.44$189.36$196.95+17.55%
October, 2028$200.17$191.49$203.26+22.91%
November, 2028$208.33$199.29$209.36+27.92%
December, 2028$214.08$208.02$219.40+31.45%

Neurocrine Biosciences Inc Stock (NBIX) Price Forecast for 2029

The 2029 price forecast for Neurocrine Biosciences Inc Stock (NBIX) is $238.25 on average, with a high prediction of $269.76 and a low estimate of $205.76. This represents an +46.29% increase from the previous price of $162.86.

MonthAverageLowHighChange from today's price
January, 2029$207.53$207.47$217.33+27.43%
February, 2029$211.30$205.76$219.65+29.74%
March, 2029$220.54$210.72$224.59+35.41%
April, 2029$236.41$220.15$239.31+45.16%
May, 2029$247.02$234.76$248.40+51.67%
June, 2029$236.57$233.50$248.66+45.26%
July, 2029$245.22$235.55$255.44+50.57%
August, 2029$244.18$238.10$253.19+49.93%
September, 2029$251.38$243.88$253.86+54.35%
October, 2029$244.78$239.54$255.09+50.30%
November, 2029$256.80$243.06$261.50+57.68%
December, 2029$257.24$249.68$269.76+57.95%

Neurocrine Biosciences Inc Stock (NBIX) Price Forecast for 2030

Neurocrine Biosciences Inc Stock (NBIX) is expected to reach an average price of $240.95 in 2030, with a high forecast of $272.90 and a low forecast of $204.99. This signifies an +47.95% surge from the last price of $162.86.

MonthAverageLowHighChange from today's price
January, 2030$235.38$231.17$267.32+44.53%
February, 2030$228.03$224.98$236.92+40.01%
March, 2030$235.19$225.24$246.18+44.42%
April, 2030$242.80$231.09$245.27+49.08%
May, 2030$256.38$241.48$256.76+57.43%
June, 2030$261.10$253.18$262.66+60.32%
July, 2030$239.65$231.96$272.90+47.15%
August, 2030$231.78$224.81$239.99+42.32%
September, 2030$222.36$204.99$236.32+36.54%
October, 2030$237.59$220.15$252.34+45.89%
November, 2030$248.17$238.11$249.59+52.38%
December, 2030$253.01$245.66$254.90+55.35%

Similar to NBIX